The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial
Ayurveda is one of the most advanced sciences of its times
The safety profile of LAGEVRIO in this trial was generally consistent with that observed in previously reported clinical studies
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
Canagliflozin and Metformin Hydrochloride Tablets had annual sales of US $49.4 million in the United States
Data build on previously reported results from the primary endpoint of investigator-assessed radiographic progression-free survival
FDA also accepts a separate supplemental application to extend prophylaxis with PREVYMIS to 200 days in certain HSCT recipients
Subscribe To Our Newsletter & Stay Updated
